| About the author: |
Vastyanov R.S., Dzygal O.F., Gorlitsyna О.А., Mykhailenko V.L., Lapshyn D.Ye., Nazarenko O.Ya. |
| Heading |
EXPERIMENTAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
The purpose of the study is to investigate the liver cirrhosis pathophysiological mechanisms in rats and to investigate the efficacy of pathogenetical correction of these pathology using L–arginine aspartate and tivortin. Experimental studies proved the lipid peroxidation involvement into the liver cirrhosis pathogenetic mechanisms. The data obtained indicate the cellular apparatus of the blood participation in the pathogenetic mechanisms of the hepatocytes lesions. The data received in morphological studies are comparable with the results of biochemical investigations confirming the unified concept of pathological morpho-functional disintegration development in conditions of investigated pathology that is the basis for the multiple organ failure syndrome development. The authors argue that the positive results of both L–arginine aspartate and tivortin using in experimental liver cirrhosis are supposed to be an experimental background of these pharmacons clinical efficacy testing. |
| Tags |
experimental liver cirrhosis, lipid peroxidation, morphological disturbances, pathophysiological mechanisms, L–arginine aspartate, tivortin, pathological morpho–functional dysintegration |
| Bibliography |
- Bagriy MM, DibrovaVA Popadynets OG, Grishchuk IM. Metodyky morfolohichnykh doslidzhen. Vinnytsya: Nova knyha; 2016. 238 s. [In Ukrainian].
- Dzyubanovskyi IYa, Romanyuk TV. Suchasni pidkhody do khirurgichnoho likuvannya sindromu portalnoyi hipertenziyi. Ukrayinskyi zhurnal khirurhiyi. 2014; 1 (24): 128–133 [In Ukrainian].
- Dzygal OF, Novikova ZhO, Kokorina YuYe, Vastyanov RS. Vnesok peroksydnykh protsesiv do patohenetychnykh mekhanizmiv eksperimentalnoho tsirozu pechinky. Klinichna khirurhiya. 2017; 10: 29–32 [In Ukrainian].
- Esmembetov KI, Abdurakhmanov DT, Odintsov AV. Sovremennye predstavleniya o patogeneze, estestvennom techenii i lechenii gepatita–delta (35 let s momenta otkrytiya). Klinicheskaya meditsina. 2013; 91 (5): 22–26 [In Russian].
- Kishkun AA. Biokhimicheskie issledovaniya v klinicheskoy praktike: Rukovodstvo dlya vrachey. Moskva: MIA; 2014: 528 s. [In Russian].
- Ascione T, Flumeri GDi, Boccia G, De Caro F. Infections in patients affected by liver cirrhosis: an update. Infez. Med. 2017; 25 (2): 91–97.
- Blachier M. et al. The burden of liver disease in Europe: a review of available epidemiological data. J. Hepatol. 2013; 58: 593–608.
- Clarke W, Marzinke M. Contemporary Practice in Clinical Chemistry. New York: Academic Press; 2020. 1035 p.
- De Franchis R. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J. Hepatol. 2015; 63: 743–752.
- Garbuzenko DV. Current approaches to the management of patients with liver cirrhosis who have acute esophageal variceal bleeding. Curr. Med. Res. Opin. 2016; 32 (3): 467–475.
- Poethko-Müller C, Zimmermann R, Hamouda O, Faber M, Stark K, Ross RS, Thamm M. Epidemiology of hepatitis A, B, and C among adults in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013; 56 (5–6): 707–715.
- Ratib S, West J, Crooks CJ, Fleming KM. Diagnosis of liver cirrhosis in England, a cohort study, 1998–2009: a comparison with cancer. Am. J. Gastroenterol. 2014; 109: 190–198.
- Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014; 383: 1749–1761.
- Von Wulffen M, Clark PJ, Macdonald GA, Raj AS, Kendall BJ, Powell EE, Jones MP, Holtmann G. Liver–related mortality in countries of the developed world: an ecological study approach to explain the variability. Aliment. Pharmacol. Ther. 2016; 44: 68–77.
- Wei Wei, Yan-Song Pu, Xin-Kai Wang, An Jiang, Rui Zhou, Yu Li, Qiu-Juan Zhang, Ya-Juan Wei, Bin Chen , Zong-Fang Li. Wall shear stress in portal vein of cirrhotic patients with portal hypertension. World J. Gastroenterol. 2017; 23 (18): 3279–3232.
|
| Publication of the article |
«World of Medicine and Biology» №3(73), 2020 year, 159-164 pages, index UDK 616.36-004-091.8]-092.9 |
| DOI |
10.26724/2079-8334-2020-3-73-159-164 |
